{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,23]],"date-time":"2026-08-23T16:55:56Z","timestamp":1787504156390,"version":"build-2736575974"},"reference-count":67,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2018,3,13]],"date-time":"2018-03-13T00:00:00Z","timestamp":1520899200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Curr Neurol Neurosci Rep"],"published-print":{"date-parts":[[2018,4]]},"DOI":"10.1007\/s11910-018-0824-8","type":"journal-article","created":{"date-parts":[[2018,3,13]],"date-time":"2018-03-13T00:09:49Z","timestamp":1520899789000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":47,"title":["Coccidioidal Meningitis: A Review on Diagnosis, Treatment, and Management of Complications"],"prefix":"10.1007","volume":"18","author":[{"given":"Royce","family":"Johnson","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jackie","family":"Ho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pete","family":"Fowler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arash","family":"Heidari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,3,13]]},"reference":[{"issue":"6","key":"824_CR1","doi-asserted-by":"publisher","first-page":"847","DOI":"10.1093\/cid\/cis1028","volume":"56","author":"N Marsden-Haug","year":"2013","unstructured":"Marsden-Haug N, Goldoft M, Ralston C, Limaye AP, Chua J, Hill H, et al. Coccidioidomycosis acquired in Washington State. Clin Infect Dis. 2013;56(6):847\u201350. https:\/\/doi.org\/10.1093\/cid\/cis1028 .","journal-title":"Clin Infect Dis"},{"key":"824_CR2","unstructured":"Posadas A. Un nuevo caso de micosis fungoidea con posrospemias. Ann Cir Med Argent. 1892;15:585\u201397."},{"key":"824_CR3","unstructured":"Wernicke RJ. Pentastomas. Revista de la Sociedad Medica Argentina. 1892;1:186\u2013189."},{"key":"824_CR4","unstructured":"Rixford E, Gilchrist TC. Two cases of protozoan (coccidioidal) infection of the skin and other organs. Johns Hopkins Hosp Rep. 1896;10:209\u201368."},{"key":"824_CR5","first-page":"1471","volume":"5","author":"W Ophuls","year":"1900","unstructured":"Ophuls W, Moffitt HC. A new pathogenic mould (formerly described as a protozoan; Coccidioides immitis pyogenes), preliminary report. Phila Med J. 1900;5:1471.","journal-title":"Phila Med J."},{"key":"824_CR6","doi-asserted-by":"publisher","first-page":"1291","DOI":"10.1001\/jama.1905.52510180005002","volume":"45","author":"W Ophuls","year":"1905","unstructured":"Ophuls W. Coccidioidal granuloma. JAMA. 1905;45:1291.","journal-title":"JAMA."},{"key":"824_CR7","doi-asserted-by":"publisher","first-page":"1730","DOI":"10.1001\/jama.1910.04330200040015","volume":"55","author":"H Ryfkogel","year":"1910","unstructured":"Ryfkogel H. Coccidioidal meningitis with secondary internal hydrocephalus and death (anaphylactic) following a second injection of Flexner\u2019s serum. JAMA. 1910;55:1730.","journal-title":"JAMA."},{"issue":"2","key":"824_CR8","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1093\/clind\/16.2.247","volume":"16","author":"T Vincent","year":"1993","unstructured":"Vincent T, Galgiani JN, Huppert M, Salkin D. The natural history of coccidioidal meningitis: VA-Armed Forces cooperative studies, 1955-1958. Clin Infect Dis. 1993;16(2):247\u201354.","journal-title":"Clin Infect Dis."},{"issue":"4","key":"824_CR9","first-page":"1241","volume":"13","author":"CJ Wrobel","year":"1992","unstructured":"Wrobel CJ, Meyer S, Johnson RH, Hesselink JR. MR findings in acute and chronic coccidioidomycosis meningitis. Am J Neuroradiol. 1992;13(4):1241\u20135.","journal-title":"Am J Neuroradiol."},{"issue":"4","key":"824_CR10","doi-asserted-by":"publisher","first-page":"624","DOI":"10.1086\/427215","volume":"40","author":"EL Arsura","year":"2005","unstructured":"Arsura EL, Johnson R, Penrose J, Stewart K, Kilgore W, Reddy CM, et al. Neuroimaging as a guide to predict outcomes for patients with coccidioidal meningitis. Clin Infect Dis. 2005;40(4):624\u20137.","journal-title":"Clin Infect Dis."},{"issue":"4","key":"824_CR11","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1007\/s11908-009-0043-1","volume":"11","author":"JE Blair","year":"2009","unstructured":"Blair JE. Coccidioidal meningitis: update on epidemiology, clinical features, diagnosis, and management. Curr Infect Dis Rep. 2009;11(4):289\u201395.","journal-title":"Curr Infect Dis Rep."},{"issue":"5","key":"824_CR12","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1097\/MD.0b013e3181f378a8","volume":"89","author":"G Mathisen","year":"2010","unstructured":"Mathisen G, Shelub A, Truong J, Wigen C. Coccidioidal meningitis: clinical presentation and management in the fluconazole era. Medicine (Baltimore). 2010;89(5):251\u201384.","journal-title":"Medicine (Baltimore)."},{"issue":"6","key":"824_CR13","doi-asserted-by":"publisher","first-page":"e112","DOI":"10.1093\/cid\/ciw360","volume":"63","author":"JN Galgiani","year":"2016","unstructured":"\u2022\u2022 Galgiani JN, Ampel NM, Blair JE, Catanzaro A, Geertsma F, Hoover SE, et al. Infectious Diseases Society of America (IDSA) clinical practice guideline for the treatment of coccidioidomycosis. Clin Infect Dis. 2016;63(6):e112\u201346. Recent updated clinical infectious disease guideline on coccidioidomycosis management, including the management of coccidioidal meningitis","journal-title":"Clin Infect Dis"},{"issue":"21","key":"824_CR14","doi-asserted-by":"publisher","first-page":"1780","DOI":"10.1212\/WNL.0b013e3181c34b69","volume":"73","author":"KW Drake","year":"2009","unstructured":"Drake KW, Adam RD. Coccidioidal meningitis and brain abscesses: analysis of 71 cases at a referral center. Neurology. 2009;73(21):1780\u20136.","journal-title":"Neurology."},{"issue":"1","key":"824_CR15","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1086\/497596","volume":"42","author":"RH Johnson","year":"2006","unstructured":"Johnson RH, Einstein HE. Coccidioidal meningitis. Clin Infect Dis. 2006;42(1):103\u20137.","journal-title":"Clin Infect Dis."},{"issue":"3","key":"824_CR16","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1016\/0002-9343(93)90276-U","volume":"95","author":"AS Ragland","year":"1993","unstructured":"Ragland AS, Arsura E, Ismail Y, Johnson R. Eosinophilic pleocytosis in coccidioidal meningitis: frequency and significance. Am J Med. 1993;95(3):254\u20137.","journal-title":"Am J Med."},{"issue":"8","key":"824_CR17","doi-asserted-by":"publisher","first-page":"1003","DOI":"10.1021\/jm00194a023","volume":"22","author":"J Heeres","year":"1979","unstructured":"Heeres J, Backx LJ, Mostmans JH, Van Cutsem J. Antimycotic imidazoles. part 4. Synthesis and antifungal activity of ketoconazole, a new potent orally active broad-spectrum antifungal agent. J Med Chem. 1979;22(8):1003\u20135.","journal-title":"J Med Chem."},{"issue":"3","key":"824_CR18","doi-asserted-by":"publisher","first-page":"305","DOI":"10.7326\/0003-4819-124-3-199602010-00004","volume":"124","author":"DH Dewsnup","year":"1996","unstructured":"Dewsnup DH, Galgiani JN, Graybill JR, Diaz M, Rendon A, Cloud GA, et al. Is it ever safe to stop azole therapy for Coccidioides immitis meningitis? Ann Intern Med. 1996;124(3):305\u201310.","journal-title":"Ann Intern Med."},{"issue":"4","key":"824_CR19","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1093\/cid\/cir410","volume":"53","author":"RS Bercovitch","year":"2011","unstructured":"Bercovitch RS, Catanzaro A, Schwartz BS, Pappagianis D, Watts DH, Ampel NM. Coccidioidomycosis during pregnancy: a review and recommendations for management. Clin Infect Dis. 2011;53(4):363\u20138. https:\/\/doi.org\/10.1093\/cid\/cir410 .","journal-title":"Clin Infect Dis"},{"issue":"4","key":"824_CR20","doi-asserted-by":"publisher","first-page":"858","DOI":"10.1128\/CMR.00007-10","volume":"23","author":"R Nau","year":"2010","unstructured":"Nau R, S\u00f6rgel F, Eiffert H. Penetration of drugs through the blood-cerebrospinal fluid\/blood-brain barrier for treatment of central nervous system infections. Clin Microbiol Rev. 2010;23(4):858\u201383. https:\/\/doi.org\/10.1128\/CMR.00007-10 .","journal-title":"Clin Microbiol Rev"},{"key":"824_CR21","volume-title":"Diflucan (fluconazole) prescribing information","author":"Pfizer","year":"2014","unstructured":"Pfizer. Diflucan (fluconazole) prescribing information. New York: Pfizer; 2014."},{"key":"824_CR22","doi-asserted-by":"crossref","unstructured":"Galgiani JN, Catanzaro A, Cloud GA, Higgs J, Friedman BA, Larsen RA, et al. Fluconazole therapy for coccidioidal meningitis.. Ann Intern Med. 1993;119(1):28-35.","DOI":"10.7326\/0003-4819-119-1-199307010-00005"},{"key":"824_CR23","doi-asserted-by":"crossref","unstructured":"Tucker RM, Denning DW, Dupont B, Stevens DA. Itraconazole therapy for chronic coccidioidal meningitis. Ann Intern Med. 1990;112:108\u201312.","DOI":"10.7326\/0003-4819-112-2-108"},{"issue":"6","key":"824_CR24","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1002\/j.1552-4604.1997.tb04332.x","volume":"37","author":"D Lange","year":"1997","unstructured":"Lange D, Pavao JH, Wu J, Klausner M. J Effect of a cola beverage on the bioavailability of itraconazole in the presence of H2 blockers. Clin Pharmacol. 1997;37(6):535\u201340.","journal-title":"Clin Pharmacol."},{"key":"824_CR25","volume-title":"Onmel (itraconazole) prescribing information","author":"M Pharmaceuticals","year":"2012","unstructured":"Pharmaceuticals M. Onmel (itraconazole) prescribing information. Greensboro: Merz Pharmaceuticals; 2012."},{"issue":"4","key":"824_CR26","doi-asserted-by":"publisher","first-page":"707","DOI":"10.1128\/AAC.35.4.707","volume":"35","author":"PK Sharkey","year":"1991","unstructured":"Sharkey PK, Rinaldi MG, Dunn JF, Hardin TC, Fetchick RJ, Graybill JR. High-dose itraconazole in the treatment of severe mycoses. Antimicrob Agents Chemother. 1991;35(4):707\u201313.","journal-title":"Antimicrob Agents Chemother."},{"key":"824_CR27","volume-title":"Recent trends in the discovery, development and evaluation of antifungal agents","author":"J Heykants","year":"1987","unstructured":"Heykants J, Micheils M, Mueldermans W, Monbaliu J, Lavrijsen K, Van Peer A, et al. The pharmacokinetics of itraconazole in animals and man: an overview. In: Fromtling RA, editor. Recent trends in the discovery, development and evaluation of antifungal agents. Barcelona: Prous; 1987."},{"key":"824_CR28","unstructured":"Verweij PE, Brinkman K, Kremer HP, Kullberg BJ, Meis JF. Aspergillus meningitis: diagnosis by non-culture-based microbiological methods and management. J. Clin. Microbiol. 1999;37:1186\u20139."},{"issue":"5","key":"824_CR29","doi-asserted-by":"publisher","first-page":"728","DOI":"10.1086\/377131","volume":"37","author":"I Lutsar","year":"2003","unstructured":"Lutsar I, Roffey S, Troke P. Voriconazole concentrations in the cerebrospinal fluid and brain tissue of guinea pigs and immunocompromised patients. Clin Infect Dis. 2003;37(5):728\u201332.","journal-title":"Clin Infect Dis."},{"issue":"3","key":"824_CR30","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1086\/525258","volume":"46","author":"TJ Walsh","year":"2008","unstructured":"Walsh TJ, Anaissie EJ, Denning DW, Herbrecht R, Kontoyiannis DP, Marr KA, et al. Treatment of aspergillosis: clinical practice guidelines of the Infectious Diseases Society of America. Clin Infect Dis. 2008;46(3):327\u201360.","journal-title":"Clin Infect Dis."},{"key":"824_CR31","volume-title":"Vfend (voriconazole) prescribing information","author":"Pfizer","year":"2010","unstructured":"Pfizer. Vfend (voriconazole) prescribing information. New York: Pfizer; 2010."},{"issue":"2","key":"824_CR32","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1086\/524669","volume":"46","author":"A Pascual","year":"2008","unstructured":"Pascual A, Calandra T, Bolay S, Buclin T, Bille J, Marchetti O. Voriconazole therapeutic drug monitoring in patients with invasive mycoses improves efficacy and safety outcomes. Clin Infect Dis. 2008;46(2):201\u201311.","journal-title":"Clin Infect Dis."},{"issue":"5","key":"824_CR33","doi-asserted-by":"publisher","first-page":"562","DOI":"10.1086\/519937","volume":"45","author":"A Catanzaro","year":"2007","unstructured":"Catanzaro A, Cloud GA, Stevens DA, Levine BE, Williams PL, Johnson RH, et al. Safety, tolerance, and efficacy of posaconazole therapy in patients with nonmeningeal disseminated or chronic pulmonary coccidioidomycosis. Clin Infect Dis. 2007;45(5):562\u20138.","journal-title":"Clin Infect Dis."},{"issue":"12","key":"824_CR34","doi-asserted-by":"publisher","first-page":"1770","DOI":"10.1086\/430303","volume":"40","author":"GM Anstead","year":"2005","unstructured":"Anstead GM, Corcoran G, Lewis J, Berg D, Graybill JR. Refractory coccidioidomycosis treated with posaconazole. Clin Infect Dis. 2005;40(12):1770\u20136.","journal-title":"Clin Infect Dis."},{"issue":"3","key":"824_CR35","doi-asserted-by":"publisher","first-page":"952","DOI":"10.1378\/chest.07-0114","volume":"132","author":"DA Stevens","year":"2007","unstructured":"Stevens DA, Rendon A, Gaona-Flores V, Catanzaro A, Anstead GM, Pedicone L, et al. Posaconazole therapy for chronic refractory coccidioidomycosis. Chest. 2007;132(3):952\u20138.","journal-title":"Chest."},{"issue":"11","key":"824_CR36","doi-asserted-by":"publisher","first-page":"1060","DOI":"10.1093\/cid\/cir642","volume":"53","author":"MM Kim","year":"2011","unstructured":"Kim MM, Vikram HR, Kusne S, Seville MT, Blair JE. Treatment of refractory coccidioidomycosis with voriconazole or posaconazole. Clin Infect Dis. 2011;53(11):1060\u20136.","journal-title":"Clin Infect Dis."},{"key":"824_CR37","volume-title":"Noxafil (posaconazole) prescribing information","author":"Merck","year":"2015","unstructured":"Merck. Noxafil (posaconazole) prescribing information. Whitehouse Station: Merck; 2015."},{"key":"824_CR38","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1038\/bmt.2009.17","volume":"44","author":"M Reinwald","year":"2009","unstructured":"Reinwald M, Uharek L, Lampe D, Grobosch T, Thiel E, Schwartz S. Limited penetration of posaconazole into cerebrospinal fluid in an allogeneic stem cell recipient with invasive pulmonary aspergillosis. Bone Marrow Transplant. 2009;44:269\u201370.","journal-title":"Bone Marrow Transplant."},{"key":"824_CR39","doi-asserted-by":"publisher","first-page":"1468","DOI":"10.1093\/jac\/dkn409","volume":"62","author":"MJ R\u00fcping","year":"2008","unstructured":"R\u00fcping MJ, Albermann N, Ebinger F, Burckhardt I, Beisel C, M\u00fcller C, et al. Posaconazole concentrations in the central nervous system. J Antimicrob Chemother. 2008;62:1468\u201370.","journal-title":"J Antimicrob Chemother."},{"issue":"12","key":"824_CR40","doi-asserted-by":"publisher","first-page":"1252","DOI":"10.1093\/cid\/cir734","volume":"53","author":"R Schein","year":"2011","unstructured":"Schein R, Homans J, Larsen RA, Neely M. Posaconazole for chronic refractory coccidioidal meningitis. Clin Infect Dis. 2011;53(12):1252\u20134.","journal-title":"Clin Infect Dis."},{"issue":"7","key":"824_CR41","doi-asserted-by":"publisher","first-page":"4020","DOI":"10.1128\/AAC.02448-13","volume":"58","author":"WK Kraft","year":"2014","unstructured":"Kraft WK, Chang PS, van Iersel ML, Waskin H, Krishna G, Kersemaekers WM. Posaconazole tablet pharmacokinetics: lack of effect of concomitant medications altering gastric pH and gastric motility in healthy subjects. Antimicrob Agents Chemother. 2014;58(7):4020\u20135.","journal-title":"Antimicrob Agents Chemother."},{"issue":"11","key":"824_CR42","doi-asserted-by":"publisher","first-page":"2725","DOI":"10.1093\/jac\/dks268","volume":"67","author":"G Krishna","year":"2012","unstructured":"Krishna G, Ma L, Martinho M, Preston RA, O'Mara E. A new solid oral tablet formulation of posaconazole: a randomized clinical trial to investigate rising single- and multiple-dose pharmacokinetics and safety in healthy volunteers. J Antimicrob Chemother. 2012;67(11):2725\u201330.","journal-title":"J Antimicrob Chemother."},{"key":"824_CR43","volume-title":"Cresemba (isavuconazonium) prescribing information","author":"Astellas Pharma US","year":"2015","unstructured":"Astellas Pharma US. Cresemba (isavuconazonium) prescribing information. Northbrook: Astellas Pharma US; 2015."},{"key":"824_CR44","first-page":"163","volume":"6","author":"DR Falci","year":"2013","unstructured":"Falci DR, Pasqualotto AC. Profile of isavuconazole and its potential in the treatment of severe invasive fungal infections. Infect Drug Resist. 2013;6:163\u201374.","journal-title":"Infect Drug Resist."},{"issue":"3","key":"824_CR45","doi-asserted-by":"publisher","first-page":"356","DOI":"10.1093\/cid\/ciw305","volume":"63","author":"GR Thompson 3rd","year":"2016","unstructured":"Thompson GR 3rd, Rendon A, Ribeiro Dos Santos R, Queiroz-Telles F, Ostrosky-Zeichner L, Azie N, et al. Isavuconazole treatment of cryptococcosis and dimorphic Mycoses. Clin Infect Dis. 2016;63(3):356\u201362. https:\/\/doi.org\/10.1093\/cid\/ciw305 .","journal-title":"Clin Infect Dis"},{"issue":"4","key":"824_CR46","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1053\/srin.2001.29298","volume":"16","author":"DA Stevens","year":"2001","unstructured":"Stevens DA, Shatsky SA. Intrathecal amphotericin in the management of coccidioidal meningitis. Semin Respir Infect. 2001;16(4):263\u20139.","journal-title":"Semin Respir Infect."},{"issue":"4","key":"824_CR47","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1093\/cid\/ciw794","volume":"64","author":"J Ho","year":"2017","unstructured":"\u2022 Ho J, Fowler P, Heidari A, Johnson RH. Intrathecal amphotericin B: a 60-year experience in treating coccidioidal meningitis. Clin Infect Dis. 2017;64(4):519\u201324. This article describes the 60-year practical experience in the treatment of coccidioidal meningitis, preparation of intrathecally delivered amphotericin B deoxycholate, and the different dosing strategies used in cisternal, lumbar, and ventricular administration","journal-title":"Clin Infect Dis"},{"key":"824_CR48","doi-asserted-by":"publisher","first-page":"242","DOI":"10.7326\/0003-4819-95-2-242_2","volume":"95","author":"ML Sievers","year":"1981","unstructured":"Sievers ML, Fisher JR. Coccidioidal meningitis and intrathecal corticosteroids. Ann Intern Med. 1981;95:242\u20133.","journal-title":"Ann Intern Med."},{"key":"824_CR49","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1097\/00005792-198105000-00001","volume":"60","author":"E Bouza","year":"1981","unstructured":"Bouza E, Dreyer JS, Hewitt WL, Meyer RD. Coccidioidal meningitis. an analysis of thirty-one cases and review of the literature. Medicine (Baltimore). 1981;60:139\u201372.","journal-title":"Medicine (Baltimore)"},{"issue":"8","key":"824_CR50","doi-asserted-by":"publisher","first-page":"2420","DOI":"10.1128\/AAC.46.8.2420-2426.2002","volume":"46","author":"KV Clemons","year":"2002","unstructured":"Clemons KV, Sobel RA, Williams PL, Pappagianis D, Stevens DA. Efficacy of intravenous liposomal amphotericin B (AmBisome) against coccidioidal meningitis in rabbits. Antimicrob Agents Chemother. 2002;46(8):2420\u20136.","journal-title":"Antimicrob Agents Chemother."},{"issue":"5","key":"824_CR51","doi-asserted-by":"publisher","first-page":"1858","DOI":"10.1128\/AAC.01538-08","volume":"53","author":"KV Clemons","year":"2009","unstructured":"Clemons KV, Capilla J, Sobel RA, Martinez M, Tong AJ, Stevens DA. Comparative efficacies of lipid-complexed amphotericin B and liposomal amphotericin B against coccidioidal meningitis in rabbits. Antimicrob Agents Chemother. 2009;53(5):1858\u201362.","journal-title":"Antimicrob Agents Chemother."},{"issue":"5","key":"824_CR52","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1111\/j.1745-7599.2005.0030.x","volume":"17","author":"CH Snyder","year":"2005","unstructured":"Snyder CH. Coccidioidal meningitis presenting as memory loss. J Am Acad Nurse Pract. 2005;17(5):181\u20136.","journal-title":"J Am Acad Nurse Pract."},{"issue":"3","key":"824_CR53","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1093\/clinids\/14.3.673","volume":"14","author":"PL Williams","year":"1992","unstructured":"Williams PL, Johnson R, Pappagianis D, Einstein H, Slager U, Koster FT, et al. Vasculitic and encephalitic complications associated with Coccidioides immitis infection of the central nervous system in humans: report of 10 cases and review. Clin Infect Dis. 1992;14(3):673\u201382.","journal-title":"Clin Infect Dis."},{"key":"824_CR54","first-page":"339","volume":"94","author":"HE Einstein","year":"1961","unstructured":"Einstein HE, Holeman CW Jr, Sandidge LL, Holden DH. Coccidioidal meningitis. The use of amphotericin B in treatment. Calif Med. 1961;94:339\u201343.","journal-title":"Calif Med."},{"issue":"1","key":"824_CR55","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1001\/archinte.1981.00340010067015","volume":"141","author":"RC Stadalnik","year":"1981","unstructured":"Stadalnik RC, Goldstein E, Hoeprich PD, McGahan JP. Use of radiologic modalities in coccidioidal meningitis. Arch Intern Med. 1981;141(1):75\u20138.","journal-title":"Arch Intern Med."},{"issue":"3","key":"824_CR56","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1086\/649858","volume":"50","author":"JR Perfect","year":"2010","unstructured":"Perfect JR, Dismukes WE, Dromer F, Goldman DL, Graybill JR, Hamill RJ, et al. Clinical practice guidelines for the management of cryptococcal disease: 2010 update by the Infectious Diseases Society of America. Clin Infect Dis. 2010;50(3):291\u2013322.","journal-title":"Clin Infect Dis."},{"issue":"1","key":"824_CR57","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1086\/313603","volume":"30","author":"JR Graybill","year":"2000","unstructured":"Graybill JR, Sobel J, Saag M, van Der Horst C, Powderly W, Cloud G, et al. Diagnosis and management of increased intracranial pressure in patients with AIDS and cryptococcal meningitis. Clin Infect Dis. 2000;30(1):47\u201354.","journal-title":"Clin Infect Dis."},{"issue":"2","key":"824_CR58","doi-asserted-by":"publisher","first-page":"400","DOI":"10.1093\/clinids\/20.2.400","volume":"20","author":"PS Mischel","year":"1995","unstructured":"Mischel PS, Vinters HV. Coccidioidomycosis of the central nervous system: neuropathological and vasculopathic manifestations and clinical correlates. Clin Infect Dis. 1995;20(2):400\u20135.","journal-title":"Clin Infect Dis."},{"issue":"3","key":"824_CR59","first-page":"773","volume":"47","author":"JH Romeo","year":"2000","unstructured":"Romeo JH, Rice LB, McQuarrie IG. Hydrocephalus in coccidioidal meningitis: case report and review of the literature. Neurosurgery. 2000;47(3):773\u20137.","journal-title":"Neurosurgery."},{"issue":"4","key":"824_CR60","doi-asserted-by":"publisher","first-page":"1217","DOI":"10.1086\/515689","volume":"178","author":"PL Williams","year":"1998","unstructured":"Williams PL, Sobel RA, Sorensen KN, Clemons KV, Shuer LM, Royaltey SS, et al. A model of coccidioidal meningoencephalitis and cerebrospinal vasculitis in the rabbit. J Infect Dis. 1998;178(4):1217\u201321.","journal-title":"J Infect Dis."},{"key":"824_CR61","first-page":"CD002244","volume":"1","author":"K Prasad","year":"2008","unstructured":"Prasad K, Singh MB. Corticosteroids for managing tuberculous meningitis. Cochrane Database Syst Rev. 2008;1:CD002244.","journal-title":"Cochrane Database Syst Rev."},{"issue":"20","key":"824_CR62","doi-asserted-by":"publisher","first-page":"1549","DOI":"10.1056\/NEJMoa021334","volume":"347","author":"J Gans de","year":"2002","unstructured":"de Gans J, van de Beek D. Dexamethasone in adults with bacterial meningitis. N Engl J Med. 2002;347(20):1549\u201356.","journal-title":"N Engl J Med."},{"issue":"12","key":"824_CR63","first-page":"1374","volume":"145","author":"WA Kennedy","year":"1991","unstructured":"Kennedy WA, Hoyt MJ, McCracken GH Jr. The role of corticosteroid therapy in children with pneumococcal meningitis. Am J Dis Child. 1991;145(12):1374\u20138.","journal-title":"Am J Dis Child."},{"issue":"4","key":"824_CR64","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1053\/srin.2001.29319","volume":"16","author":"PL Williams","year":"2001","unstructured":"Williams PL. Vasculitic complications associated with coccidioidal meningitis. Semin Respir Infect. 2001;16(4):270\u20139.","journal-title":"Semin Respir Infect."},{"key":"824_CR65","unstructured":"Galgiani J, Ampel N, Blair J, Catanzaro A, Geertsma F, Hoover S, Johnson R, Stevens D, Sunenshine R. Panel discussion of the new coccidiodomycosis guidelines presented at the 7th international coccidioidomycosis symposium, Palo Alto, 13 August 2017."},{"issue":"2","key":"824_CR66","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1093\/cid\/cix318","volume":"65","author":"GR Thompson 3rd","year":"2017","unstructured":"\u2022 Thompson GR 3rd, Blair J, Wang S, Bercovitch R, Bolaris M, Van Den Akker D, et al. Adjunctive corticosteroid therapy in the treatment of coccidioidal meningitis. Clin Infect Dis. 2017;65(2):338\u20134. This recent multicenter retrospective cohort study found that patients with cerebrovascular events associated with coccidioidal meningitis may benefit from adjunctive short-term corticosteroid use","journal-title":"Clin Infect Dis"},{"issue":"2","key":"824_CR67","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1093\/clinids\/22.2.240","volume":"22","author":"AF Ba\u00f1uelos","year":"1996","unstructured":"Ba\u00f1uelos AF, Williams PL, Johnson RH, Bibi S, Fredricks DN, Gilroy SA, et al. Central nervous system abscesses due to Coccidioides species. Clin Infect Dis. 1996;22(2):240\u201350.","journal-title":"Clin Infect Dis."}],"container-title":["Current Neurology and Neuroscience Reports"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11910-018-0824-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11910-018-0824-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11910-018-0824-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,2]],"date-time":"2025-07-02T15:00:05Z","timestamp":1751468405000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11910-018-0824-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,3,13]]},"references-count":67,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2018,4]]}},"alternative-id":["824"],"URL":"https:\/\/doi.org\/10.1007\/s11910-018-0824-8","relation":{},"ISSN":["1528-4042","1534-6293"],"issn-type":[{"value":"1528-4042","type":"print"},{"value":"1534-6293","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,3,13]]},"assertion":[{"value":"13 March 2018","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical Standards"}},{"value":"The authors declare that they have no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}},{"value":"This article does not contain any studies with humans or animals performed by any of the authors.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Human and Animal Rights and Informed Consent"}}],"article-number":"19"}}